C
Cognition Therapeutics, Inc. (CGTX)
NCM – Real Time Price. Currency in USD
1.18
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.18
0.00 (0.00%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $37.0M significantly exceed its total debt $638.0K, ensuring strong financial flexibility
Total current assets $48.0M exceed Total current liabilities $13.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-2,734.2x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.4M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.45 | 6.05 | 10 | |
| Quick ratio | 3.45 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | -2734.20 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -235K | -252K | -266K | -228K | -228K |
| Operating Income | -44M | -51M | -54M | -48M | -48M |
| Net Income | -21M | -26M | -34M | -23M | -23M |
| EBITDA | -43M | -50M | -54M | -48M | -48M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 40.91 | 5.5 |
| Next quarter | N/A | -16.67 | 1.0 |
| Current year | N/A | 1.56 | 2.0 |
| Next year | N/A | 4.76 | 2.5 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 32.19 | 37.64 | 39.18 | 10 |
| Y/Y | 999 | 57.37 | 80.17 | 59 | 10 |
| 3y average | 999 | -7.11 | 22.76 | -16.3 | 5.5 |
| 5y average | 999 | -30.68 | 34.8 | -93.28 | 5.5 |
| Weighted average score | 7.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |